Biotech sell-off continues

iShares NASDAQ Biotech Index (IBB -3.2%) down 3% on heavy volume in early trading.

Modest support at 235 is holding. If it fails, the next point of resistance is ~225.

Money flow has been decidedly negative for the past four weeks.


From other sites
Comments (5)
  • the_value_vulture
    , contributor
    Comments (434) | Send Message
    Looks to me like babies are being thrown out with the bath water. Long idix and thrx.
    24 Mar 2014, 12:07 PM Reply Like
  • alan ljl
    , contributor
    Comments (271) | Send Message
    "Sell when people are greedy. Buy when people are fearful."-Buffet et al
    Now is the time to buy GILD, ALXN, CELG..... 25%-30% projected EPS growth rates.
    24 Mar 2014, 12:31 PM Reply Like
  • Heem
    , contributor
    Comments (229) | Send Message
    This isn't a "catch a falling knife" event, but the sector could drop a lot more taking good biotech stocks with it.
    24 Mar 2014, 01:02 PM Reply Like
  • sheldond
    , contributor
    Comments (1412) | Send Message
    A nice head fake in the short term although I am watching margin account holders. How are they holding up opprtunities could present themselves. I am holding long only three biotech in my portfolio mostly for speed. I think the run is not yet over.
    It is definitely something to watch.


    24 Mar 2014, 02:08 PM Reply Like
  • ken1chris
    , contributor
    Comments (8) | Send Message
    Gileed is a proven efficacious drug; but the price undoubtedly has Obama care concerned.
    25 Mar 2014, 03:03 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs